71
Participants
Start Date
October 21, 2021
Primary Completion Date
December 29, 2023
Study Completion Date
December 29, 2023
Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement for the treatment of a failed surgical aortic valve bioprosthesis, Valve-in-Valve (ViV), in patients who were considered to be at increased risk for redo surgical aortic valve replacement
GenesisCare - St Andrew's Hospital & GenesisCare Leabrook - Satellite Site of GenesisCare - Wesley Hospital, Adelaide
Rigshospitalet, Copenhagen
Kerckhoff-Klinik gGmbH, Bad Nauheim
Universitätsklinikum Rostock (AöR), Rostock
Morriston Hospital - ABM University Health Board, Morriston
GenesisCare - Wesley Hospital, Auchenflower
St. Bartholomew's Hospital, London
Lead Sponsor
Abbott Medical Devices
INDUSTRY